enGene Therapeutics

ENGN

Börsenwert 106 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Kennedy Capital Management St Louis, Missouri	464.912 $	-640.386 $	-157.046	-37 %
27	27 Woodline Partners San Francisco, California	432.500 $	–	–	–
28	28 Squarepoint New York	372.609 $	+678.864 $	+166.482	+340 %
29	29 Elmind Capital New York	363.300 $	–	–	–
30	30 Qube Research & Technologies (QRT) London, United Kingdom	346.324 $	+816.303 $	+200.187	Neu
31	31 Privium Fund Management Amsterdam, Netherlands	294.100 $	-742.496 $	-182.087	-52 %
32	32 Two Sigma Investments New York	284.706 $	+22.431 $	+5.501	+3 %
33	33 XTX Topco George Town, Cayman Islands	261.964 $	+236.213 $	+57.928	+62 %
34	34 Marquette Asset Management Minneapolis, Minnesota	260.445 $	+613.881 $	+150.546	Neu
35	35 Persistent Asset Partners Hong Kong	198.073 $	+466.868 $	+114.493	Neu
36	36 DAFNA Capital Management Los Angeles, California	129.145 $	-459.569 $	-112.703	-60 %
37	37 Jain Global New York	74.790 $	+176.283 $	+43.231	Neu
38	38 Scientech Research LLC Jersey City, New Jersey	70.428 $	+166.003 $	+40.710	Neu
39	39 Verdad Advisers Boston, Massachusetts	67.989 $	+160.254 $	+39.300	Neu
40	40 Dimensional Fund Advisors Austin, Texas	66.243 $	+5.782 $	+1.418	+4 %
41	41 GSA Capital Partners London, United Kingdom	65.000 $	+152.286 $	+37.346	Neu
42	42 Morgan Stanley New York	57.239 $	-218.214 $	-53.514	-62 %
43	43 Engineers Gate Manager New York	47.205 $	+111.264 $	+27.286	Neu
44	44 BNP Paribas Financial Markets Paris, France	43.975 $	-162.627 $	-39.882	-61 %
45	45 Susquehanna International Group Bala Cynwyd, Pennsylvania	42.333 $	+99.781 $	+24.470	Neu
46	46 Sectoral Asset Management Montreal, Quebec, Canada	37.541 $	+88.486 $	+21.700	Neu
47	47 Raymond James Financial St Petersburg, Florida	36.946 $	+1.456 $	+357	+2 %
48	48 SEI Investments Oaks, Pennsylvania	32.012 $	-169.355 $	-41.532	-69 %
49	49 HRT Financial New York	29.000 $	-61.924 $	-15.186	-47 %
50	50 Fountainhead AM Warren, New Jersey	25.950 $	+61.166 $	+15.000	Neu

enGene Therapeutics ENGN Börsenwert 106 Mio. $

enGene Therapeutics

ENGN

Börsenwert 106 Mio. $